---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-010213"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:25:22.183137+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences approves 1:50 reverse stock split, increases authorized shares to 1B, appoints new Head of Finance

## Summary
- Senior Director of Finance Irina Pestrikova resigned Aug 7; Richard Jacroux appointed Head of Finance & principal financial officer on Aug 8.
- Stockholders approved increase in authorized common shares from 80M to 1B; amendment filed Aug 8.
- Board set reverse stock split ratio at 1-for-50, authorized by stockholders (range 1:20 to 1:50).
- At Aug 6 annual meeting: all five director nominees elected; say-on-pay, warrant issuance, and auditor ratification passed.

## SEC filing metadata
- accession: 0001654954-24-010213
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495424010213/0001654954-24-010213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495424010213/ndra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-010213
- JSON: https://secwatch.observer/filing/0001654954-24-010213.json
- Plain text: https://secwatch.observer/filing/0001654954-24-010213.txt

## Key facts
- Executive change
  Richard Jacroux was appointed as Head of Finance at ENDRA Life Sciences Inc..
  - Action: appointed
  - Role: Head of Finance
  source text: On August 8, 2024, the Company’s Board of Directors (the “Board of Directors”) appointed Richard Jacroux as Head of Finance.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681682/000165495424010213/0001654954-24-010213-index.htm
- Executive change
  Irina Pestrikova resigned as Senior Director, Finance at ENDRA Life Sciences Inc..
  - Action: resigned
  - Role: Senior Director, Finance
  source text: On August 5, 2024, Irina Pestrikova notified ENDRA Life Sciences Inc. (“ENDRA” or the “Company”) of her resignation as the Company’s Senior Director, Finance, effective August 7, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681682/000165495424010213/0001654954-24-010213-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.